CV Sciences, Inc. (CVSI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US1266541028
CV Sciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 13.79 m USD |
| Gross profit | 6.75 m USD |
| Operating income | -470,000.00 USD |
| EBIT | -432,000.00 USD |
| Net income | -958,000.00 USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CV Sciences, Inc.
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
More stocks
- KALA BIO, Inc. (KALA)
- Quantum Genesis AI Corp. (QGAI)
- My City Builders, Inc. (MYCB)
- Dror Ortho-Design, Inc. (DROR)
- GBT Technologies Inc. (GTCH)
- Nuwellis, Inc. (NUWE)
- PSQ Holdings, Inc. (PSQH)
- BioNexus Gene Lab Corp (BGLC)
- Iveda Solutions, Inc. (IVDA)
- ADAMANT DRI PROCESSING & MINERALS GROUP (ADMG)
- RELIABILITY INC (RLBY)
- Co-Diagnostics, Inc. (CODX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.